@bgr.com 1 year ago
Trial begins for radioactive gel that painlessly kills skin cancer in seconds
@RadiologyGamuts 1 year ago
#AI in Radiology article alert: The 3<sup>rd</sup> ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy (Radiother Oncol) http://doi.org/10.1016/j.radonc.2022.02.012 #ML #MachineLearning https://t.co/tf6twQc1Ai
@RadiologyGamuts 1 year ago
#AI in Radiology article alert: The 3<sup>rd</sup> ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy (Radiother Oncol) http://doi.org/10.1016/j.radonc.2022.02.012 #ML #MachineLearning https://t.co/b0rfZfi4aj
@TheraPanacea 3 years ago
In 30 minutes it will be too late... Our showcase "The future is here: learn how AI is already transforming radiotherapy workflow" is now! #AAPM2020 #AAPMCOMP2020 @AAPMHQ #AI #radiotherapy #innovation #machinelearning fight #cancer #MedPhys #MedicalPhysic https://t.co/G4d2C5pxp3
@BristowColin 5 years ago
Cancer Risk Assessment in Modern Radiotherapy Workflow With Medical Big Data Read more here: https://ift.tt/2LICSpy #BigData #DataScience #MachineLearning #DeepLearning #NLP #Robots #AI #IoT #Finserv
@IainLJBrown 5 years ago
Cancer Risk Assessment in Modern Radiotherapy Workflow With Medical Big Data Read more here: https://ift.tt/2LICSpy #BigData #DataScience #MachineLearning #DeepLearning #NLP #Robots #AI #IoT
@venturebeat.com 6 years ago
Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference
@venturebeat.com 6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com 6 years ago
Augmenix Partners with Us TOO International to Stream Live Webcast and Q & A on Prostate Cancer Radiation Therapy
@venturebeat.com 6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com 6 years ago
Augmenix to Unveil New Clinical Data on its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation Oncology
@venturebeat.com 6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com 6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com 6 years ago
Augmenix Ranked as One of America’s Fastest-Growing Private Companies for Second Year
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com 6 years ago
SpaceOAR® System Receives Shonin Approval in Japan
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com 7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com 7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com 7 years ago
Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference
@venturebeat.com 7 years ago
Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30
@venturebeat.com 7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material
@ahier 7 years ago
Applying #MachineLearning to radiotherapy planning for head/neck #cancer http://bit.ly/2bBNyFv via @DeepMindAI #AI https://t.co/rQ72axuefx